Robins Harlan S

Chief Scientific OfficerAdaptive Biotechnologies Corp (ADPT) · full profile →Form 4 · filed Jul 23, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10.8M
Net Open-Market Flow
-$10.8M
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 21, 2026Option exercise(M)285K$6.55$1.9M1.3M
Jul 21, 2026Sell(S)279K$21.72$6.1M1.0M
Jul 21, 2026Sell(S)214K$22.12$4.7M812K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 21, 2026Option exercise(M)285K$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001780851-26-000017) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.